查看购物车
  • Traditional Chinese
  • English
欧洲骨关节浸润关节内注射市场规模和预测（2021 - 2031）、区域份额、趋势和成长机会分析报告涵盖范围：按类型、最终用户（医院、骨科诊所等）和国家/地区
市场调查报告书
商品编码
1571399

欧洲骨关节浸润关节内注射市场规模和预测（2021 - 2031）、区域份额、趋势和成长机会分析报告涵盖范围：按类型、最终用户（医院、骨科诊所等）和国家/地区

Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, End User (Hospitals, Orthopedic Clinics, and Others), and Country
出版日期: | 出版商: The Insight Partners | 英文 92 Pages | 订单完成后即时交付

价格

欧洲关节内注射骨关节浸润市场规模预计将从2023年的9,743万美元成长到2031年的1,5708万美元；预计 2023 年至 2031 年复合年增长率为 6.2%。

治疗骨关节炎的关节内注射是一种将药物直接注射到受骨关节炎影响的关节的医疗程序。这种方法旨在减轻疼痛并改善关节功能。医疗保健专业人员和患者对这些注射的好处的认识不断提高，加上对医疗保健基础设施和创新的投资不断增加，正在促进更多人获得这些治疗。骨关节炎盛行率的增加和注射技术的进步是导致欧洲骨关节浸润关节内注射市场规模扩大的重要因素。然而，与关节内注射相关的副作用阻碍了欧洲关节内注射用于骨关节浸润市场的成长。

关节内注射是治疗骨关节浸润的创新和新兴领域之一。製造商参与各种临床试验，以确保创新药物的安全性、有效性和可靠性。例如，2024年5月，瑞典公司Synartro发起了37,3至736万美元的融资，用于骨关节炎候选药物SYN321的临床研究。目前正处于获得欧盟 278 万美元赠款的最后阶段。此外，2023年4月，该公司获得瑞典医疗产品局和瑞典伦理审查局的批准，启动在研药物SYN321的1/2a期首次人体临床研究。该地区的其他市场参与者也在进行关节内注射的临床试验，这可以促进创新产品的开发。例如，2022年8月，德国Grunenthal公司在其树脂毒素（RTX）全球临床III期计画中招募了第一位患者。 Grunenthal 在欧洲、美国、拉丁美洲、南非和日本的约 200 个地点进行了三项试验，以调查成人关节内注射 RTX 的安全性和有效性。试验中观察到的结果主要集中在西安大略大学和麦克马斯特大学 (WOMAC) 骨关节炎指数从基线到 52 週的身体功能和疼痛评分的改善。完成后，第三阶段计划旨在为 RTX 在欧洲、美国和日本提供行销批准。该公司拟于2024年提交新药申请，预示着RTX可能在2025年进入市场。几年的成长。

基于类型的见解

根据类型，欧洲骨关节浸润关节内注射市场分为 1 型胶原蛋白和透明质酸。到 2023 年，透明质酸细分市场将占据欧洲最大的骨关节浸润关节内注射市场。透明质酸注射疗法的最新进展显着扩大了生长轨迹。大力关注在市场上开发和推出新产品预计将支持该细分市场的成长，从而促进市场成长。

疾病管制与预防中心、世界卫生组织和国家生物技术资讯中心是在准备欧洲关节内注射骨关节浸润市场报告时参考的主要和次要来源之一。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第 4 章：欧洲关节内注射骨关节浸润市场格局

  • 概述
  • PEST分析
  • 关于为什么胶原蛋白注射比 HA 注射更好的信息
  • 定价分析

第 5 章：欧洲骨关节浸润关节内注射市场 - 主要市场动态

  • 欧洲骨关节浸润关节内注射市场 - 主要市场动态
  • 市场驱动因素
    • 骨关节炎盛行率上升
    • 注射技术的进步
  • 市场限制
    • 与关节内注射相关的副作用
  • 市场机会
    • 关节内注射治疗骨关节浸润的策略性倡议
  • 未来趋势
    • 临床试验数量不断增加
  • 驱动因素和限制的影响：

第 6 章：欧洲关节内注射骨关节浸润市场分析

  • 欧洲骨关节浸润关节内注射市场收入，2021-2031年
  • 欧洲骨关节浸润关节内注射市场预测与分析

第 7 章：欧洲骨关节浸润关节内注射市场分析 - 按类型

  • 1 型胶原蛋白
  • 玻尿酸

第 8 章：欧洲骨关节浸润关节内注射市场分析 - 按下最终用户

  • 医院
  • 骨科诊所
  • 其他的

第 9 章：欧洲骨关节浸润关节内注射市场 - 国家分析

  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 欧洲其他地区

第 10 章：产业格局

  • 概述
  • 骨关节浸润市场关节内注射的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 11 章：公司简介

  • Bioventus Inc
  • SEIKAGAKU CORPORATION
  • Maxigen Biotech Inc.
  • ?stem Medical Inc.
  • Sanofi SA
  • Ferring Pharmaceuticals
  • Fidia Pharma USA Inc.
  • Biotech Healthcare Group
  • Bioteck S.p.A.
  • I+MED

第 12 章：附录

Product Code: TIPRE00039338

The Europe intra-articular injection for osteoarticular infiltrations market size is expected to grow from US$ 97.43 million in 2023 to US$ 157.08 million by 2031; it is projected to register a CAGR of 6.2% during 2023-2031.

Intra-articular injections for osteoarthritis are a medical procedure where medication is injected directly into a joint affected by osteoarthritis. This approach is intended to reduce pain and improve joint function. Increasing awareness among healthcare professionals and patients regarding the benefits of these injections, combined with increasing investment in healthcare infrastructure and innovation, is facilitating increased access to these treatments. The increasing prevalence of osteoarthritis and advancements in injection techniques are noteworthy factors contributing to the expansion of the Europe intra-articular injection for osteoarticular infiltrations market size. However, the side effects associated with intra-articular injections hinder the Europe intra-articular injection for osteoarticular infiltrations market growth.

Intra-articular injections are among the innovative and emerging fields of treatment for osteoarticular infiltrations. Manufacturers are involved in various clinical trials to ensure the safety, efficacy, and reliability of innovative drugs. For instance, in May 2024, the Swedish Company, Synartro, initiated a capital raise of between US$ 3.73 and 7.36 million to conduct a clinical study of the osteoarthritis candidate SYN321. It is in the final phase to secure an EU grant of US$ 2.78 million. Additionally, in April 2023, the company received approval from the Swedish Medical Products Agency and the Swedish Ethical Review Authority to start the phase 1/2a first-in-human clinical study of the investigational drug candidate SYN321. Other market players in the regions are also conducting clinical trials for intra-articular injections, which can lead to the development of innovative products. For instance, in August 2022, Grunenthal, a German company enrolled the first patient in its global clinical Phase III program for resiniferatoxin (RTX). Grunenthal has conducted three trials in ~200 locations across Europe, the US, Latin America, South Africa, and Japan to investigate the safety and effectiveness of intra-articular injections of RTX in adults. The outcomes observed in the trials mainly focus on an improvement in the physical function and pain score in the Western Ontario and McMaster Universities (WOMAC) osteoarthritis index from baseline to 52 weeks. Upon completion, the Phase III program is intended to provide marketing approval for RTX in Europe, the US, and Japan. The company intends to submit a new drug application in 2024, indicating the potential market entry of RTX in 2025. Therefore, the increasing number of clinical trials are expected to enhance the development of innovative products in the region, which, in turn, will contribute to the Europe intra-articular injection for osteoarticular infiltrations market growth in coming years.

Type-Based Insights

Based on type, the Europe intra-articular injection for osteoarticular infiltrations market is segmented into Type 1 collagen and hyaluronic acid. The hyaluronic acid segment held the largest Europe intra-articular injection for osteoarticular infiltrations market share in 2023 Hyaluronic acid injections are employed to treat knee pain in patients who were not responsive to other treatment options. Recent advancements in hyaluronic acid injection therapy have significantly expanded growth trajectory. A robust focus on developing and introducing novel products in the market is expected to support the growth of the segment, thereby contributing to market growth.

The Centers for Disease Control and Prevention, World Health Organization, and National Center for Biotechnology Information are among the primary and secondary sources referred to while preparing the Europe intra-articular injection for osteoarticular infiltrations market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Information on why collagen injections are better than HA injections
  • 4.4 Pricing Analysis

5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Key Market Dynamics

  • 5.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Prevalence of Osteoarthritis
    • 5.2.2 Advancements in Injection Techniques
  • 5.3 Market Restraints
    • 5.3.1 Side Effects Associated with Intra-Articular Injections
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives in Intra-Articular Injection for Osteoarticular Infiltrations
  • 5.5 Future Trends
    • 5.5.1 Increasing Number of Clinical Trials
  • 5.6 Impact of Drivers and Restraints:

6. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis

  • 6.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue (US$ Million), 2021-2031
  • 6.2 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Forecast and Analysis

7. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis - by Type

  • 7.1 Type 1 Collagen
    • 7.1.1 Overview
    • 7.1.2 Type 1 Collagen: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Hyaluronic Acid
    • 7.2.1 Overview
    • 7.2.2 Hyaluronic Acid: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis - by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Hospitals: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Orthopedic Clinics
    • 8.2.1 Overview
    • 8.2.2 Orthopedic Clinics: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Others
    • 8.3.1 Overview
    • 8.3.2 Others: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Country Analysis

  • 9.1 Europe
    • 9.1.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Countries
    • 9.1.2 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue and Forecast and Analysis - by Country
      • 9.1.2.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue and Forecast and Analysis - by Country
      • 9.1.2.2 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.2.1 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.2.2 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.2.3 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
      • 9.1.2.3 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.3.1 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.3.2 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.3.3 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
      • 9.1.2.4 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.4.1 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.4.2 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.4.3 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
      • 9.1.2.5 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.5.1 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.5.2 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.5.3 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
      • 9.1.2.6 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.6.1 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.6.2 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.6.3 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
      • 9.1.2.7 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.7.1 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.7.2 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.7.3 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
      • 9.1.2.8 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.8.1 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.8.2 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.8.3 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Bioventus Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 SEIKAGAKU CORPORATION
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Maxigen Biotech Inc.
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 ?stem Medical Inc.
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Sanofi SA
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Ferring Pharmaceuticals
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Fidia Pharma USA Inc.
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Biotech Healthcare Group
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Bioteck S.p.A.
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 I+MED
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Segmentation
  • Table 2. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 6. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Country
  • Table 7. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 8. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 9. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 10. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 11. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 12. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 13. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 14. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 15. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 16. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 17. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 18. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 19. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 20. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 21. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 22. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 23. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 24. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 25. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 26. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 27. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 28. Recent Organic Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market
  • Table 29. Recent Inorganic Growth Strategies in the Intra-Articular Injection For Osteoarticular Infiltrations Market
  • Table 30. Glossary of Terms, Europe Intra-Articular Injection For Osteoarticular Infiltrations Market

List Of Figures

  • Figure 1. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue (US$ Million), 2021-2031
  • Figure 5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Share (%) - by Type, 2023 and 2031
  • Figure 6. Type 1 Collagen: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Hyaluronic Acid: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Share (%) - by End User, 2023 and 2031
  • Figure 9. Hospitals: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Orthopedic Clinics: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Others: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Key Countries, 2023 and 2031 (%)
  • Figure 13. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market